Novo Nordisk A/Sās popular Wegovy weight-loss pill disappointed investors with sales that failed to live up to the hype of an obesity drug whose launch was billed the most successful in history.
Source: [Bloomberg Markets](https://www.bloomberg.com/news/articles/2026-08-04/novo-nordisk-boosts-forecast-on-soaring-glp-1-sales)